Innovation Partner
PharmaLegacy
A leading CRO since 2008, PharmaLegacy provides in vivo pharmacology services with over 1500 clinically predictive animal disease models, covering inflammation/autoimmune diseases, immuno-oncology/oncology, metabolic diseases, ophthalmology, cardiovascular diseases, CNS, bone, and hearing loss, etc. across species from rodents to NHPs. We specialize in integrating PK, PD, and ex-vivo endpoints into study designs and conducting ADME assays and non-GLP and GLP toxicology studies. PharmaLegacy has successfully validated more than 60 ocular disease animal models, some of which are exclusive at PharmaLegacy. We also specialize in all kinds of intraocular deliveries such as intravitreal, subretinal, suprachoroidal injections. Our Shanghai headquarter and San Diego site feature AAALAC accredited vivariums.
Exhibition Partner
Vitranu
Vitranu, Inc. pioneers cutting-edge sustained drug delivery solutions through its innovative injectable microcapsule technology. This patented system revolutionizes pharmaceutical administration by offering precise, controlled, and extended-release of unprocessed active ingredients, preserving their full therapeutic potential. With applications spanning ophthalmology and emerging biologics, Vitranu addresses critical unmet needs, enhancing patient outcomes and reducing treatment burdens. By advancing drug delivery standards, Vitranu is poised to transform healthcare and establish itself as a cornerstone in pharmaceutical innovation.
